信使核糖核酸
翻译(生物学)
癌症
癌症治疗
临床试验
癌症治疗
医学
癌症研究
癌细胞
细胞内
临床实习
输送系统
生物信息学
临床疗效
转化研究
临床治疗
计算生物学
作者
Hyun-Jin Kim,Ngoc Duy Le,Hyun-Ji Oh,Beomsu Kim,Eunjae Yoo,Jeonghwan Kim,Hyungshin Yim
摘要
mRNA technology and the lipid nanoparticle (LNP) platform have gained significant research attention for other therapeutic applications, particularly cancer treatment, after the success of COVID-19 mRNA vaccines. The flexibility, scalability, and safety of mRNA render it suitable for pharmaceutical applications, and recent advances in mRNA engineering have further improved both its stability and translational durability. The LNP platform has been instrumental in the clinical translation of mRNA therapy by enabling intracellular delivery and supporting access to both hepatic and extrahepatic organs. However, the lack of tumor-specific LNPs hinders the successful development of mRNA-based cancer therapy. In this review, we discussed the basic biology of mRNA and the benefits of mRNA therapy for cancer treatment. We highlighted how the LNP platform works and its important role in mRNA-based cancer therapy. We also looked into ways to improve the physicochemical properties of LNPs for cancer treatment. Clinical trials are reviewed to provide the current status of mRNA-LNP technology in cancer therapy. We conclude with a discussion of the challenges and future prospects for developing LNPs capable of mRNA delivery effectively for cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI